🇺🇸 미국주식 도서
박종훈의 미국주식투자 레시피 : 경제뉴스 꿀조합과 투자…
18,000원
최소한의 주식투자:ETF부터 코스피·미국 주식까지 평생…
19,800원
박종훈의 미국주식투자 레시피:월가의 정보를 수익으로 바…로켓
18,000원
이 포스팅은 쿠팡 파트너스 활동의 일환으로, 이에 따른 일정액의 수수료를 제공받습니다.
| 항목 | 2024-06 | 2024-09 | 2024-12 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | $56.33B | N/A | N/A | N/A | $61.16B | N/A |
| Net Income | $1.37B | $1.56B | $-22.00M | $1.29B | $938.00M | $186.00M | $1.82B | $695.00M |
| EPS (Diluted) | $0.77 | $0.88 | $-0.02 | $0.72 | $0.52 | $0.10 | $1.02 | $0.39 |
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; ...
🔗 emfls.com 다른 콘텐츠 보기